The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real world outcomes of 177Lu-PSMA-617 PSMA in a racially diverse cohort of patients with metastatic castration resistant prostate cancer (mCRPC).
 
Margo Gerke
Stock and Other Ownership Interests - Abbvie; Amgen; Danaher; Merck; Stryker; Thermo Fisher Scientific; United Health Group; United Health Group
 
Angelo Marra
No Relationships to Disclose
 
Yuan Liu
No Relationships to Disclose
 
Saima Muzahir
No Relationships to Disclose
 
Jacqueline Brown
Consulting or Advisory Role - Exelixis; Xencor
Research Funding - Hookipa Pharma (Inst); Medicenna (Inst); Merck (Inst); Surface Oncology (Inst); Xencor (Inst)
 
Bassel Nazha
Honoraria - Intellisphere, LLC (Onclive)
Consulting or Advisory Role - Cardinal Health; Exelixis; IntrinsiQ
 
Jacob Berchuck
Stock and Other Ownership Interests - Cityblock Health (I); Genome Medical; Musculo; Oncotect; Precede Bio; TracerDx
Honoraria - Guardant Health
Consulting or Advisory Role - Genome Medical; Guardant Health; Musculo; Oncotect; Precede Bio; TracerDx
Speakers' Bureau - Guardant Health
Research Funding - Guardant Health (Inst); Precede Bio (Inst)
Patents, Royalties, Other Intellectual Property - Institutional patent filed on methods for detecting prostate cancer resistance using cell-free DNA
Travel, Accommodations, Expenses - Guardant Health
 
Ravi Parikh
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb; GNS Healthcare; Merck; Onc.AI; Thyme Care; Verve Therapeutics
Honoraria - Wake Forest School of Medicine
Consulting or Advisory Role - Archetype Therapeutics; Biofourmis; ConcertAI; Credit Suisse; G1 Therapeutics; Humana; Klick Inc; Merck; NanOlogy; Onc.ai; Thyme Care
Research Funding - Arnold Ventures (Inst); Commonwealth Fund (Inst); Emerson Collective (Inst); Mendel AI (Inst); Prostate Cancer Foundation (Inst); Schmidt Futures (Inst)
Patents, Royalties, Other Intellectual Property - Technology to integrate patient-reported outcomes into electronic health record algorithms
 
Jordan Ciuro
No Relationships to Disclose
 
Caitlin Hartman
No Relationships to Disclose
 
Greta McClintock
No Relationships to Disclose
 
Sarah Caulfield
No Relationships to Disclose
 
Omer Kucuk
No Relationships to Disclose
 
Bradley Carthon
No Relationships to Disclose
 
David Schuster
Consulting or Advisory Role - Global Medical Solutions Taiwan; Progenics Pharmaceuticals, Inc; Heidelberg University; DuChemBio Co. Ltd.; Telix Pharmaceuticals Limited.
Research Funding - Blue Earth Diagnostics, Ltd; Blue Earth Therapeutics, Ltd; Nihon MediPhysics Co, Ltd.; Telix Pharmaceuticals (US) Inc.; Advanced Accelerator Applications; Xencor; Amgen Inc.
Patents, Royalties, Other Intellectual Property - Inventor(s): Miller, Matthew (Oxford, GB), Gauden, David (Oxford, GB), Schuster, David (Atlanta, GA), Fanti, Stefano (Bologna, IT), Nanni, Cristina (Bologna, IT), Zanoni, Lucia (Bologna, IT), Willoch, Frode (Oslo, NO), Bogsrud, Trond Velde (Oslo, NO), Bac
Other Relationship - PrecisCa; School of Breast Oncology
 
Mehmet Bilen
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Calithera Biosciences; Eisai; EMD Serono; Exelixis; Exelixis; Genomic Health; Janssen; Nektar; Pfizer; Sanofi; SeaGen
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech/Roche (Inst); Genome & Company (Inst); Incyte (Inst); Merck (Inst); Nektar (Inst); NiKang Therapeutics (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Seagen (Inst); Tricon Pharmaceuticals (Inst); Xencor (Inst)